Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence.

[1]  Edouard Vannier,et al.  Clinical, hematologic, and immunologic effects of interleukin-10 in humans , 1996, Journal of Clinical Immunology.

[2]  L Scola,et al.  Gender-specific association between −1082 IL-10 promoter polymorphism and longevity , 2002, Genes and Immunity.

[3]  Malbea A Lapete,et al.  Prevention and Control of Influenza Recommendations of the Advisory Committee on Immunization Practices ( ACIP ) , 2004 .

[4]  N. Letvin,et al.  CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses. , 2001, Current opinion in immunology.

[5]  S. Grottoli,et al.  Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH1−24 , 2001, Clinical endocrinology.

[6]  Bente Klarlund Pedersen,et al.  Aging and proinflammatory cytokines , 2001, Current opinion in hematology.

[7]  D. Wodarz.  Cytotoxic T-lymphocyte memory, virus clearance and antigenic heterogeneity , 2001, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[8]  Li Wu,et al.  Molecular and cellular mediators of interleukin-1-dependent acute inflammatory arthritis. , 2001, Arthritis and rheumatism.

[9]  B. Johansson,et al.  Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study , 2001, Mechanisms of Ageing and Development.

[10]  V. Emery.  Cytomegalovirus and the Aging Population , 2001, Drugs & aging.

[11]  W. B. van den Berg,et al.  Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis. , 2000, The American journal of pathology.

[12]  J. Myśliwska,et al.  Lower interleukin-2 and higher serum tumor necrosis factor-a levels are associated with perimenstrual, recurrent, facial Herpes simplex infection in young women. , 2000, European cytokine network.

[13]  S. Castle.  Impact of age-related immune dysfunction on risk of infections , 2000, Zeitschrift für Gerontologie und Geriatrie.

[14]  C. Akdis,et al.  A molecular basis for T cell suppression by IL‐10: CD28‐associated IL‐10 receptor inhibits CD28 tyrosine phosphorylation and phosphatidylinositol 3‐kinase binding , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  H. Ochs,et al.  Progressive specific immune attrition after primary, secondary and tertiary immunizations with bacteriophage ΦX174 in asymptomatic HIV-1 infected patients , 2000, AIDS.

[16]  L. Gagnon,et al.  D-LysAsnProTyr tetrapeptide: a novel B-cell stimulant and stabilized bursin mimetic. , 2000, Vaccine.

[17]  R. Webster,et al.  Immunity to influenza in the elderly. , 2000, Vaccine.

[18]  F. Visseren,et al.  Interleukin-6 production by endothelial cells after infection with influenza virus and cytomegalovirus. , 1999, The Journal of laboratory and clinical medicine.

[19]  J. Myśliwska,et al.  The upregulation of TNFα production is not a generalised phenomenon in the elderly between their sixth and seventh decades of life , 1999, Mechanisms of Ageing and Development.

[20]  E. Gardner,et al.  Cytokine production after influenza vaccination in a healthy elderly population. , 1998, Vaccine.

[21]  K. Nichol,et al.  Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. , 1998, Archives of internal medicine.

[22]  C. Feighery,et al.  Quantitative intracellular cytokine measurement: age‐related changes in proinflammatory cytokine production , 1998, Clinical and experimental immunology.

[23]  Merino,et al.  Progressive decrease of CD8high+ CD28+ CD57− cells with ageing , 1998, Clinical and experimental immunology.

[24]  J. Myśliwska,et al.  Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by the health status , 1998, Mechanisms of Ageing and Development.

[25]  A. Kumar,et al.  IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha. , 1996, Journal of immunology.

[26]  L. Rink,et al.  Dysregulation between TH1 and TH2 T cell subpopulations in the elderly , 1996, Mechanisms of Ageing and Development.

[27]  G. Ligthart,et al.  Influenza vaccination for all elderly. , 1996, Gerontology.

[28]  M. Girndt,et al.  Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. , 1995, Kidney international.

[29]  G. Dinant,et al.  The Efficacy of Influenza Vaccination in Elderly Individuals: A Randomized Double-blind Placebo-Controlled Trial , 1994 .

[30]  A. Gerber,et al.  1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections , 1994 .

[31]  G. Palù,et al.  Humoral and cellular immune response to influenza virus vaccination in aged humans , 1993, Aging.

[32]  G. Lüchters,et al.  Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature. , 1993, Vaccine.

[33]  D. Knook,et al.  Necessity of the assessment of health status in human immunogerontological studies: Evaluation of the senieur protocol , 1990, Mechanisms of Ageing and Development.